Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion type Assertion NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_head.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion description "[By immunocytochemistry, Western blotting and flow cytometry analysis, oestrogen treatment of R2d cells was found to induce many important effects related to breast carcinogenesis, namely: (i) the emergence of a subpopulation of cells expressing CD44+/high/CD24-/low breast tumour stem cell markers; (ii) the induction of EMT (epithelial-to-mesenchymal transition); (iii) the acquisition of metastatic ability; and (iv) the expression of COX-2 (cyclo-oxygenase-2) through a CD44-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_provenance.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion evidence source_evidence_literature NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_provenance.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion SIO_000772 19895368 NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_provenance.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion wasDerivedFrom befree-20140225 NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_provenance.
- NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_assertion wasGeneratedBy ECO_0000203 NP837907.RAj1U2DBNTBZsxj8WvFUyHaswtnXm5dD-tGlGvFZsDRKI130_provenance.